CADL logo

Candel Therapeutics (CADL) Operating Profit

Annual Operating Profit

-$38.39 M
-$3.72 M-10.72%

31 December 2023

CADL Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Profit

-$8.76 M
-$186.00 K-2.17%

30 September 2024

CADL Quarterly Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Operating Profit

-$35.58 M
+$92.00 K+0.26%

30 September 2024

CADL TTM Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CADL Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.7%+1.0%+1.4%
3 y3 years-191.2%-10.9%-54.5%
5 y5 years---

CADL Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-191.2%at low-15.4%+15.4%-54.5%+7.3%
5 y5 years-353.5%at low-306.4%+15.4%-1551.2%+7.3%
alltimeall time-353.5%at low-306.4%+15.4%-1551.2%+7.3%

Candel Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sept 2024
-
-$8.76 M(+2.2%)
-$35.58 M(-0.3%)
June 2024
-
-$8.57 M(+8.5%)
-$35.68 M(-2.7%)
Mar 2024
-
-$7.90 M(-23.7%)
-$36.67 M(-4.5%)
Dec 2023
-$38.39 M(+10.7%)
-$10.35 M(+17.0%)
-$38.39 M(+6.4%)
Sept 2023
-
-$8.85 M(-7.5%)
-$36.09 M(-0.1%)
June 2023
-
-$9.57 M(-0.6%)
-$36.12 M(+2.3%)
Mar 2023
-
-$9.62 M(+19.5%)
-$35.31 M(+1.8%)
Dec 2022
-$34.67 M
-$8.05 M(-9.3%)
-$34.67 M(+1.4%)
Sept 2022
-
-$8.88 M(+1.5%)
-$34.21 M(+3.0%)
June 2022
-
-$8.75 M(-2.6%)
-$33.23 M(+13.9%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$8.99 M(+18.4%)
-$29.17 M(+18.3%)
Dec 2021
-$24.65 M(+86.9%)
-$7.59 M(-3.9%)
-$24.65 M(+7.0%)
Sept 2021
-
-$7.90 M(+68.2%)
-$23.03 M(+29.9%)
June 2021
-
-$4.70 M(+5.2%)
-$17.73 M(+14.4%)
Mar 2021
-
-$4.47 M(-25.2%)
-$15.50 M(+17.5%)
Dec 2020
-$13.19 M(+55.8%)
-$5.97 M(+130.2%)
-$13.19 M(+82.8%)
Sept 2020
-
-$2.60 M(+5.4%)
-$7.21 M(+56.2%)
June 2020
-
-$2.46 M(+14.3%)
-$4.62 M(+114.3%)
Mar 2020
-
-$2.15 M
-$2.15 M
Dec 2019
-$8.47 M
-
-

FAQ

  • What is Candel Therapeutics annual operaing income?
  • What is the all time high annual operating profit for Candel Therapeutics?
  • What is Candel Therapeutics annual operating profit year-on-year change?
  • What is Candel Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Candel Therapeutics?
  • What is Candel Therapeutics quarterly operating profit year-on-year change?
  • What is Candel Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Candel Therapeutics?
  • What is Candel Therapeutics TTM operating profit year-on-year change?

What is Candel Therapeutics annual operaing income?

The current annual operating profit of CADL is -$38.39 M

What is the all time high annual operating profit for Candel Therapeutics?

Candel Therapeutics all-time high annual operaing income is -$8.47 M

What is Candel Therapeutics annual operating profit year-on-year change?

Over the past year, CADL annual operaing income has changed by -$3.72 M (-10.72%)

What is Candel Therapeutics quarterly operating income?

The current quarterly operating profit of CADL is -$8.76 M

What is the all time high quarterly operating profit for Candel Therapeutics?

Candel Therapeutics all-time high quarterly operating income is -$2.15 M

What is Candel Therapeutics quarterly operating profit year-on-year change?

Over the past year, CADL quarterly operating income has changed by +$92.00 K (+1.04%)

What is Candel Therapeutics TTM operating income?

The current TTM operating profit of CADL is -$35.58 M

What is the all time high TTM operating profit for Candel Therapeutics?

Candel Therapeutics all-time high TTM operating income is -$2.15 M

What is Candel Therapeutics TTM operating profit year-on-year change?

Over the past year, CADL TTM operating income has changed by +$506.00 K (+1.40%)